Macular Edema Secondary to Branch Retinal Vein Occlusion
1 clinical trials · Condition
◉ Watch Macular Edema Secondary to Branch Retinal Vein Occlusion
| Record | Firm | Date |
|---|---|---|
| Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) (NCT01976338) | Novartis Pharmaceuticals | 2013-11-12 |
Track Macular Edema Secondary to Branch Retinal Vein Occlusion automatically
Every clearance here is in the API, with alerts when new ones post.